(Q43670383)

25 November 2017

title

Ovarian function during use of vaginal rings delivering three different doses of Nestorone (English)

1 reference

25 November 2017

Brache V

1

1 reference

25 November 2017

Mishell DR

2

1 reference

25 November 2017

Lahteenmaki P

3

1 reference

25 November 2017

Alvarez F

4

1 reference

25 November 2017

Elomaa K

5

1 reference

25 November 2017

Jackanicz T

6

1 reference

25 November 2017

Faundes A

7

1 reference

25 November 2017

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

63

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

257-261

1 reference

Contraception by means of a Silastic vaginal ring impregnated with medroxyprogesterone acetate

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol andd-norgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Bleeding and ovulation control with use of a small contraceptive vaginal ring releasing levonorgestrel and estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Levonorgestrel and estradiol release from an improved contraceptive vaginal ring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Pharmacodynamics of a contraceptive vaginal ring releasing 3-keto-desogestrel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

The 3-keto-desogestrel/ethinylestradiol ring: a new parenteral form of hormonal contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Acceptability of the Contraceptive Vaginal Ring by rural and urban population in two Latin American countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Nestorone: a progestin with a unique pharmacological profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Clinical trial with Nestorone subdermal contraceptive implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Ovarian function during use of Nestorone(R) subdermal implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27 micrograms/24 hours: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Norplant consensus statement and background review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and D-norgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900199-8

10.1016/S0010-7824(01)00199-8

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference